Jpmorgan Chase & Co »

Rani Therapeutics Hldgs shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $12k 3.7k 3.32
2023-09-30 $9.7k 4.4k 2.17
2023-06-30 $27k 6.5k 4.12
2023-03-31 $7.3k 1.4k 5.07
2022-12-31 $5.0k 789 6.34
2022-06-30 $12k 1.2k 10.10
2022-03-31 $31k 2.3k 13.31
2021-12-31 $67k 4.2k 16.11